Zynerba Pharmaceuticals, Inc.
NASDAQ:ZYNE
1.3 (USD) • At close October 10, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -35.036 | -37.309 | -51.337 | -32.944 | -39.911 | -32.012 | -23.389 | -12.551 | -5.67 | -0.637 |
| Depreciation & Amortization
| 0.219 | 0.247 | 0.207 | 0.134 | 0.1 | 0.094 | 0.075 | 0.026 | 0.027 | 0.049 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 4.332 | 5.811 | 5.178 | 5.562 | 6.626 | 5.647 | 3.269 | 1.601 | 0 | 0 |
| Change In Working Capital
| 7.458 | -2.206 | 4.638 | -7.57 | 0.789 | 0.429 | -0.493 | 1.138 | 0.197 | 0.47 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.071 | -0.724 | -2.145 | 0.21 | 1.103 | 1.492 | 1.044 | 0.536 | 0.14 | 0.086 |
| Other Working Capital
| 7.387 | -1.482 | 6.783 | -7.78 | -0.315 | -1.063 | -1.538 | 0.602 | 0.056 | 0.383 |
| Other Non Cash Items
| 0 | 0 | 0 | 0 | 0 | 0 | 0.099 | 0 | 1.905 | 0 |
| Operating Cash Flow
| -23.027 | -33.457 | -41.314 | -34.818 | -32.397 | -25.842 | -20.438 | -9.787 | -3.541 | -0.118 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.154 | -0.048 | -0.445 | -0.129 | -0.287 | -0.115 | -0.11 | -0.216 | -0.02 | -0.003 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.154 | -0.048 | -0.445 | -0.129 | -0.287 | -0.115 | -0.11 | -0.216 | -0.02 | -0.003 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 6.557 | 43.194 | 31.707 | 45.187 | 29.938 | 57.293 | 10.001 | 42.122 | 0.001 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 6.014 | 42.156 | 30.853 | 45.247 | 29.938 | 57.502 | 10.001 | 42.186 | 12.736 | 0.109 |
| Financing Cash Flow
| 6.014 | 42.156 | 30.853 | 45.247 | 29.938 | 57.502 | 10.001 | 42.186 | 12.736 | 0.109 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -17.167 | 8.651 | -10.906 | 10.299 | -2.747 | 31.544 | -10.547 | 32.182 | 9.176 | -0.011 |
| Cash At End Of Period
| 50.641 | 67.808 | 59.157 | 70.063 | 59.764 | 62.51 | 30.966 | 41.513 | 9.331 | 0.155 |